EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HeLa CELLS
Cancer-testis antigens (CTA) can be used as a target for immunotherapy of various malignant tumors, including cervical cancer. However, immunotherapy is often used in combination with anthracycline chemotherapy, in particular, doxorubicin (DXR). Their effects upon expression of CTA genes have not be...
Saved in:
Main Authors: | D. S. Kutilin, Kh. A. Mogushkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2019-07-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1827 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01) -
Thiram Effects on HeLa TI Cells
by: Varvara Maksimova, et al.
Published: (2024-04-01) -
ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
by: I. N. Mikhaylova, et al.
Published: (2021-06-01) -
Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
by: Lina Lin, et al.
Published: (2021-12-01) -
Cancer-testis antigen MAGE-C1/ CT7 in multiple myeloma: literature review
by: E. A. Makunina
Published: (2020-12-01)